Cargando…
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
Epilepsy of infancy with migrating focal seizures is a devastating pediatric neurologic disorder that often results in treatment-resistant seizure activity and developmental delay. The condition has been associated with mutations in the KCNT1 gene that cause a gain of function in neuronal sodium-act...
Autores principales: | Passey, Camerin C., Erramouspe, John, Castellanos, Peter, O'Donnell, Elizabeth C., Denton, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677567/ https://www.ncbi.nlm.nih.gov/pubmed/31388363 http://dx.doi.org/10.1016/j.curtheres.2019.02.002 |
Ejemplares similares
-
Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants
por: Ferretti, Alessandro, et al.
Publicado: (2022) -
Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review
por: Jia, Yu, et al.
Publicado: (2019) -
Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy
por: Kravetz, M. C., et al.
Publicado: (2021) -
Efficacy of Anti-seizure Medications, Quinidine, and Ketogenic Diet Therapy for KCNT1-Related Epilepsy and Genotype-Efficacy Correlation Analysis
por: Lin, Zehong, et al.
Publicado: (2022) -
Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy – Clinical Characteristics and Outcome of Targeted Treatment with Quinidine
por: Patil, Abhijit Anil, et al.
Publicado: (2019)